drugset / Trial / NCT06212102
Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this randomized controlled trial is to compare the efficacy and cost-effectiveness of using progestin with GnRH antagonist to prevent premature LH surge in poor responders undergoing double stimulation protocol.
Timeline
- Start
- 2024-05-08
- Primary completion
- 2027-03-01
- Completion
- 2027-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cetrorelix | Other / unclassified | 0.2 mg | — |
| Subject | Dydrogesterone | Other / unclassified | 30 mg | — |
| Background | HMG | Unknown | 300 iu | — |